Applications open for Capital BioVentures’ ASCENT program

Calling early-stage Canadian therapeutics company looking to rise to the next level!

Capital BioVentures is excited to launch ASCENT, a game-changing program designed to prepare early-stage Canadian therapeutic companies for investor readiness and long-term success.

What to Expect:

• Expert-led seminars, hands-on workshops, and 1:1 coaching from veteran biotech execs

• Invaluable investor feedback sessions and ‘test-the-waters’ intros

• Pitch deck + data room development, and a full gap analysis

• Top performers gain access to the Ridge program and become part of the Capital BioVentures’ portfolio

  What to Expect:

• Apply by: September 5, 2025

• Program starts: October 14, 2025

• Pitch event: March 10, 2026
  
  Who Should Apply:

• Canadian, therapeutic-focused companies

• Pre-seed or seed stage

• At least 1 full-time employee

• Minimum $250K raised (including non-dilutive funding)

  
  Write to the team for more info.